Form 4 for BVS Bioventus Inc.

Accepted 2022-06-22 00:00:00 ET · period of report 2022-06-16 · accession 0000899243-22-023642 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-22	2022-06-16	BVS	Beyer Pat	Dir	M - OptEx	$0.00	+965	965	New	$0
D	2022-06-22	2022-06-16	BVS	Beyer Pat	Dir	M - OptEx	$0.00	-965	1,930	-33%	$0
D	2022-06-22	2022-06-17	BVS	Beyer Pat	Dir	A - Grant	$0.00	+16.6K	16.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A common stock	2022-06-16	M	A	965	$0.00	965	D	—	—
2	Derivative	Restricted Stock Units	2022-06-16	M	D	965	$0.00	1,930	D	— · — to —	965 Class A Common Stock	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The remaining RSUs shall vest and become exercisable in two approximately equal installments on June 16, 2023 and June 16, 2024, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.
3	Derivative	Restricted Stock Units	2022-06-17	A	A	16,648	$0.00	16,648	D	— · — to —	16,648 Class A Common Stock	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F3) The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.